


The Fund aims to achieve a long-term return, in excess of the long-term return that is typically achieved from US Smaller companies equity markets ('“the US'”).
| Name | % Net Assets | 
|---|---|
| Phillips-Van Heusen | 2.3% | 
| Tellabs | 2.3% | 
| Omniture | 2.2% | 
| Inverness Medical Innovations | 2.0% | 
| Solera | 2.0% | 
| Reinsurance Group America | 2.0% | 
| Bank of The Ozarks | 1.9% | 
| Western Alliance Bancorp | 1.9% | 
| Hanover Insurance Group | 1.8% | 
| Pactiv | 1.8% | 
| Key | % Net Assets | 
|---|---|
| 2.3% | |
| 2.3% | |
| 2.2% | |
| 2.0% | |
| 91.2% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/02/1990 | 
|---|---|
| Fund Manager | Chuck Purcell / Bill Gerlach | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | -0.03 | 
You are here: research